Antiaversive effects of 5HT2C receptor agonists and fluoxetine in a model of panic-like anxiety in rats. (Q48406106)

11 February 2018

title

Antiaversive effects of 5HT2C receptor agonists and fluoxetine in a model of panic-like anxiety in rats. (English)

1 reference

11 February 2018

1 reference

Jenck F

1

1 reference

11 February 2018

Moreau JL

2

1 reference

11 February 2018

Berendsen HH

3

1 reference

11 February 2018

Boes M

4

1 reference

11 February 2018

Broekkamp CL

5

1 reference

11 February 2018

Martin JR

6

1 reference

11 February 2018

Wichmann J

7

1 reference

11 February 2018

Van Delft AM

8

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 August 1998

1 reference

11 February 2018

European Neuropsychopharmacology

published in

1 reference

11 February 2018

volume

8

1 reference

11 February 2018

issue

3

1 reference

11 February 2018

page(s)

161-168

1 reference

11 February 2018

Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

Effects of antidepressants on intracellular Ca2+ mobilization in CHO cells transfected with the human 5-HT2C receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

Attenuation of chemically induced defence response by 5-HT1 receptor agonists administered into the periaqueductal gray

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

Comparison of stimulus properties of fluoxetine and 5-HT receptor agonists in a conditioned taste aversion procedure.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

Animal models for anxiety and response to serotonergic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

Does it matter which serotonin receptor is doing what?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

Binding of typical and atypical antipsychotics to 5-HT1C and 5-HT2 sites: clozapine potently interacts with 5-HT1C sites

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

5-HT and mechanisms of defence

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

Learning motivated by electrical stimulation of the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder; a double-blind comparative study with fluvoxamine and maprotiline

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

5-HT2C receptor-mediated phosphoinositide turnover and the stimulus effects of m-chlorophenylpiperazine.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

Increased 5-HT2C receptor responsiveness occurs on rearing rats in social isolation.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

N-(1-methyl-5-indolyl)-N'-(3-pyridyl)urea hydrochloride: the first selective 5-HT1C receptor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

Role of 5-HT in stress, anxiety, and depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

1-(m-chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

Brain lipids that induce sleep are novel modulators of 5-hydroxytrypamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

Evidence for a role of 5-HT1C receptors in the antiserotonergic properties of some antidepressant drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

Opposite control mediated by central 5-HT1A and non-5-HT1A (5-HT1B or 5-HT1C) receptors on periaqueductal gray aversion

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

Dorsal periaqueductal gray-induced aversion as a simulation of panic anxiety: elements of face and predictive validity.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

The effect of antidepressants on aversive periaqueductal gray stimulation in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

Effect of SB 200646A, a 5-HT2C/5-HT2B receptor antagonist, in two conflict models of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

Clozapine and N-desmethylclozapine are potent 5-HT1C receptor antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

Clonazepam as an augmenting agent in the treatment of childhood-onset obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

Region-selective reduction of brain serotonin turnover rate and serotonin agonist-induced behavior in mice treated with clonazepam

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

Effects of daily oral m-chlorophenylpiperazine in elderly depressed patients. Initial experience with a serotonin agonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

The distribution and cellular localization of the serotonin 1C receptor mRNA in the rodent brain examined by in situ hybridization histochemistry. Comparison with receptor binding distribution.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

5-HT1c receptor is a prominent serotonin receptor subtype in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

Effects of repeated mild stress and two antidepressant treatments on the behavioral response to 5HT1C receptor activation in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

5HT2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

Sensations Evoked by Stimulation in the Midbrain of Man

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

Panic attacks. A neurochemical overview of models and mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

A double-blind study of adjuvant buspirone hydrochloride in clomipramine-treated patients with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

Novel regulation of 5-HT1C receptors: down-regulation induced both by 5-HT1C/2 receptor agonists and antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

Escape and approach induced by brain stimulation:A parametric analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

m-Chlorophenylpiperazine (mCPP) is an antagonist at the cloned human 5-HT2B receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

Effects of the 5-HT1A receptor agonist flesinoxan in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

New findings in the treatment of panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900055-2

7 January 2021

10.1016/S0924-977X(97)00055-2

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

9716307

1 reference

11 February 2018